{"transactions":[{"id":1425897,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88090,"kind":"person","name":"Chen Ivan","position":1,"cik":"0001743729","reported_name":"Chen Ivan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-22T21:56:02.000Z","date":"2024-08-20","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of January 15, 2025 or the date of the Issuer's annual meeting of stockholders held in 2025, and (ii) 50% of the options will vest on the earlier of January 15, 2026 or the date of the Issuer's annual meeting of stockholders held in 2026."}],"balance_after":150000,"derivative":{"exercise_price":0.07,"expiration_date":"2034-08-20","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-24-033618","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000149315224033618/ownership.xml","form_type":"4"}},{"id":1816966,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88090,"kind":"person","name":"Chen Ivan","position":1,"cik":"0001743729","reported_name":"Chen Ivan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-03T20:15:37.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2024 or January 15, 2024 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2025 or January 15, 2025."}],"balance_after":150000,"derivative":{"exercise_price":0.12,"expiration_date":"2033-08-01","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-23-044419","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919123044419/doc4.xml","form_type":"4"}},{"id":2145769,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88090,"kind":"person","name":"Chen Ivan","position":1,"cik":"0001743729","reported_name":"Chen Ivan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-04T20:16:14.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2023 or January 15, 2023 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2024 or January 15, 2024."}],"balance_after":150000,"derivative":{"exercise_price":0.2,"expiration_date":"2032-09-30","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-22-052210","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919122052210/doc4.xml","form_type":"4"}},{"id":2205715,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88090,"kind":"person","name":"Chen Ivan","position":1,"cik":"0001743729","reported_name":"Chen Ivan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-19T20:13:27.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":300000,"price":0.15,"value":45000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was in connection with a private placement issuance by the Issuer which was approved by the Issuer's board of directors."}],"balance_after":750000,"source":{"system":"sec-edgar","filing":"0001209191-22-042557","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919122042557/doc4.xml","form_type":"4"}},{"id":2659470,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88090,"kind":"person","name":"Chen Ivan","position":1,"cik":"0001743729","reported_name":"Chen Ivan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-23T00:14:32.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2022 or January 15, 2022 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2023 or January 15, 2023."}],"balance_after":125000,"derivative":{"exercise_price":0.45,"expiration_date":"2031-06-18","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-21-042590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919121042590/doc4.xml","form_type":"4"}},{"id":3143666,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88090,"kind":"person","name":"Chen Ivan","position":1,"cik":"0001743729","reported_name":"Chen Ivan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-19T22:06:52.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2021 or January 15, 2021 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2022 or January 15, 2022."}],"balance_after":125000,"derivative":{"exercise_price":0.79,"expiration_date":"2030-05-15","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-20-030646","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120030646/doc4.xml","form_type":"4"}},{"id":3214113,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88090,"kind":"person","name":"Chen Ivan","position":1,"cik":"0001743729","reported_name":"Chen Ivan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-12T21:55:17.000Z","date":"2020-03-09","kind":"grant","acquired":true,"shares":179311,"price":0.29,"value":52000.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was in connection with a private placement issuance by the Issuer which was approved by the Issuer's board of directors."}],"balance_after":450000,"source":{"system":"sec-edgar","filing":"0001209191-20-018605","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120018605/doc4.xml","form_type":"4"}},{"id":3399317,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88090,"kind":"person","name":"Chen Ivan","position":1,"cik":"0001743729","reported_name":"Chen Ivan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-03T22:26:56.000Z","date":"2019-10-01","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2021 or January 15, 2021."}],"balance_after":125000,"derivative":{"exercise_price":0.29,"expiration_date":"2029-10-01","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-19-052409","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119052409/doc4.xml","form_type":"4"}},{"id":3479303,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88090,"kind":"person","name":"Chen Ivan","position":1,"cik":"0001743729","reported_name":"Chen Ivan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-25T21:21:41.000Z","date":"2019-05-09","kind":"purchase","acquired":true,"shares":120689,"price":0.29,"value":34999.81,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The original Form 4 Report filed May 13, 2019 stated that the number of shares acquired was 100,000 at a price of $0.35 per share. This amendment reflects an amendment to the price per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The original Form 4 Report filed May 13, 2019 stated that the number of shares acquired was 100,000 at a price of $0.35 per share. This amendment reflects an amendment to the price per share."}],"balance_after":270689,"source":{"system":"sec-edgar","filing":"0001209191-19-038981","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119038981/doc4a.xml","form_type":"4/A","original_submission_date":"2019-05-13"}},{"id":3530347,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88090,"kind":"person","name":"Chen Ivan","position":1,"cik":"0001743729","reported_name":"Chen Ivan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-13T22:03:09.000Z","date":"2019-05-09","kind":"purchase","acquired":true,"shares":100000,"price":0.35,"value":35000.0,"ownership":{"direct":true},"balance_after":250000,"source":{"system":"sec-edgar","filing":"0001209191-19-029434","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919119029434/doc4.xml","form_type":"4"}},{"id":3879339,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88090,"kind":"person","name":"Chen Ivan","position":1,"cik":"0001743729","reported_name":"Chen Ivan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-02T23:26:59.000Z","date":"2018-06-28","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020."}],"balance_after":200000,"derivative":{"exercise_price":0.652,"expiration_date":"2028-06-28","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-18-040506","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919118040506/doc4.xml","form_type":"4"}},{"id":3879338,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88090,"kind":"person","name":"Chen Ivan","position":1,"cik":"0001743729","reported_name":"Chen Ivan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-02T23:26:59.000Z","date":"2018-06-28","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of restricted stock units (the \"RSUs\").  The RSUs vest and become exercisable as follows: (i) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019 and (ii) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020."}],"balance_after":150000,"source":{"system":"sec-edgar","filing":"0001209191-18-040506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919118040506/doc4.xml","form_type":"4"}}]}